References
- Marwaha RK, Bansal D, Trehan A, Marwaha N, Varma N. Clinico-haematological profile of pure red cell aplasia in children. J Trop Pediatr 2002;48:113–116.
- Fisch P. Pure red cell aplasia. Br J Haematol 2000;111:1010–1022.
- Marmont AM. Therapy of pure red cell aplasia. Semin Hematol 1991;91:285–297.
- Kwong YL, Wong KF, Liang RHS, Chu YC, Chan LC, Chan TK. Pure red cell: Clinical features and treatment results in 16 cases. Ann Hematol 1996;72:137–140.
- Sato N, Takatani O, Hosoi T, et al. Treatment of pure red cell aplasia that is resistant to conventional immunosuppressive therapy with intermittent administration of methotrexate. Acta Hematol 1989;82:98–101.
- Firkin FC, Maher D. Cytotoxic immunosuppressive drug treatment strategy in pure red cell aplasia. Eur J Haematol 1988;41:212–217.
- Marmont AM, Peschle C, Sanguineti M, Condorellei M. Pure red cell aplasia: Response of three patients to cyclo-phosphamide and/or antilymphocyte globulin and demon-stration of two types of serum IgG inhibitors to erythropoiesis. Blood 1975;45:247–261.
- Clark DA, Dessypriss EN, Krantz SB. Studies on pure red cell aplasia XI. Results of immunosuppressive ttreatment of 37 patients. Blood 1984;63: 277–286.
- Mamiya S, Itoh T, Miura AB. Acquired pure red cell aplasia in Japan. Eur J Haematol 1997;59:199–205.
- Raghavachar A. Pure red cell aplasia: Review of treatment and proposal for a treatment strategy. Blood 1990;61:47–51.
- Williams DL, Mageed ASA, Findley H, Ragab AH. Cyclosporin in the treatment of red cell aplasia. Am J Pediatr Hematol Oncol 1987;9:314–316.
- Ozsoylu S. High dose intravenous corticosteroids treatment for patients with Diamond-Blackfan syndrome resistant or refractory to conventional treatment. Am J Pediatr Hematol Oncol 1988;10:217–231.